Table 2. Antibiotic resistance profiles of bacteria isolates.
|
P. aeruginosa, n=10 (%) |
E. coli, n=10 (%) |
S. aureus, n=10 (%) |
V. cholerae, n=10 (%) |
||||||||||
|
Antibiotics |
Disc Code |
R |
I |
S |
R |
I |
S |
R |
I |
S |
R |
I |
S |
|
Ampicillin (10 µg) |
AMP |
10 (100) |
0 (0.0) |
0 (0.0) |
8 (80) |
0 (0.0) |
2 (20) |
8 (80) |
0 (0.0) |
2 (20) |
10 (100) |
0 (0.0) |
0 (0.0) |
|
Piperacillin-tazobactam (110 µg) |
TZP |
0 (0.0) |
0 (0.0) |
10 (100) |
2 (20) |
1 (10) |
7 (70) |
ND |
ND |
ND |
0 (0.0) |
0 (0.0) |
10 (100) |
|
Cefotaxime (30 µg) |
CTX |
2 (20) |
0 (0.0) |
8 (80) |
1 (10) |
0 (0.0) |
9 (90) |
3 (30) |
0 (0.0) |
7 (70) |
2 (20) |
0 (0.0) |
8 (80) |
|
Cefuroxime (30 µg) |
CXM |
3 (30) |
0 (0.0) |
7 (70) |
7 (70) |
0 (0.0) |
3 (30) |
6 (60) |
2 (20) |
2 (20) |
4 (40) |
0 (0.0) |
6 (60) |
|
Imipenem (10 µg) |
IPM |
2 (20) |
0 (0.0) |
8 (80) |
0 (0.0) |
0 (0.0) |
10 (100) |
ND |
ND |
ND |
0 (0.0) |
0 (0.0) |
10 (100) |
|
Gentamicin (10 µg) |
CN |
5 (50) |
0 (0.0) |
5 (50) |
3 (30) |
3 (30) |
4 (40) |
0 (0.0) |
0 (0.0) |
10 (100) |
1 (10) |
0 (0.0) |
9 (90) |
|
Amikacin (30 µg) |
AN |
4 (40) |
0 (0.0) |
6 (60) |
3 (30) |
0 (0.0) |
7 (70) |
0 (0.0) |
0 (0.0) |
10 (100) |
0 (0.0) |
0 (0.0) |
10 (100) |
|
Streptomycin (10 µg) |
S |
ND |
ND |
ND |
8 (80) |
2 (20) |
0 (0.0) |
ND |
ND |
ND |
2 (20) |
0 (0.0) |
8 (80) |
|
Tetracycline (30 µg) |
TE |
10 (100) |
0 (0.0) |
0 (0.0) |
1 (10) |
2 (20) |
7 (70) |
0 (0.0) |
0 (0.0) |
10 (100) |
2 (20) |
0 (0.0) |
8 (80) |
|
Ciprofloxacin (5 µg) |
CIP |
1 (10) |
4 (40) |
5 (50) |
2 (20) |
3 (30) |
5 (50) |
10 (100) |
0 (0.0) |
0 (0.0) |
1 (10) |
0 (0.0) |
9 (90) |
|
Nalidixic Acid (30 µg) |
NA |
1 (10) |
1 (10) |
8 (80) |
1 (10) |
1 (10) |
8 (80) |
ND |
ND |
ND |
9 (90) |
0 (0.0) |
1 (10) |
|
Trimethoprim-sulfamethoxazole (25 µg) |
SXT |
1 (10) |
0 (0.0) |
9 (90) |
1 (10) |
2 (20) |
7 (70) |
2 (20) |
0 (0.0) |
8 (80) |
4 (40) |
0 (0.0) |
6 (60) |
|
Cholramphenicol (30 µg) |
C |
ND |
ND |
ND |
0 (0.0) |
4 (40) |
6 (60) |
0 (0.0) |
0 (0.0) |
10 (100) |
0 (0.0) |
2 (20) |
8 (80) |
|
Nitrofurantoin (300 µg) |
F |
0 (0.0) |
2 (20) |
8 (80) |
0 (0.0) |
0 (0.0) |
10 (100) |
2 (20) |
0 (0.0) |
8 (80) |
9 (90) |
0 (0.0) |
1 (10) |
R, Resistant; I, Intermediate; S, Sensitive